Crohn’s treat-to-target gets deeper: aiming beyond the mucosa
The VECTORS trial will test whether steering Crohn’s disease therapy toward intestinal ultrasound–defined transmural response or transmural healing—alongside clinical and biomarker remission—improves outcomes compared with targeting clinical and biomarker remission alone. In this phase 4, multicentre randomised design (~304 adults with moderately to severely active disease), all participants start vedolizumab with an additional week-10 dose and can escalate per a prespecified algorithm to reach assigned targets. The primary endpoint is corticosteroid-free endoscopic remission at week 48, with longer-term follow-up for Crohn’s-related complications at week 96.
Why it might matter to you:
If ultrasound-based transmural targets outperform symptom/biomarker targets, it could shift how you monitor response and when you escalate biologic therapy in routine care. It may also help clarify whether “deep” healing measured beyond the lumen translates into fewer strictures, fistulas, and downstream interventions over time.
ERCP services under the microscope: what a national survey reveals
This commentary discusses a UK-wide survey of ERCP practice designed to benchmark service delivery against British Society of Gastroenterology standards and other performance indicators. A notable strength is the reported 100% response from all 170 UK units providing ERCP, allowing a rare, system-level view of how the procedure is staffed, organised, and quality-assured. The piece frames ERCP as an increasingly central intervention—alongside EUS and cholangioscopy—absorbing work that previously fell to surgery or interventional radiology, and highlights how unit- and operator-level metrics can be used as practical proxies for quality.
Why it might matter to you:
For hepatobiliary and pancreatic care pathways, ERCP capacity and quality directly influence complication rates, length of stay, and access to definitive management. The survey-style benchmarking discussed here can inform how you interpret KPIs locally—what to measure, where variation is likely, and which gaps may warrant training, referral-network redesign, or service consolidation.
Fibroid surgery’s blood-loss problem: a teachable learning curve
In a retrospective case series from a teaching hospital, investigators evaluated uterine artery blockage via the anterior cul-de-sac as an adjunct to complex minimally invasive myomectomy. Among 86 consecutive patients operated on by a single surgeon, the technique was attempted in 61 cases, achieving consistent bilateral success after 34 cases—suggesting a defined proficiency threshold. The series reports operative details and outcomes in a cohort often characterised by heavy disease burden (many patients with multiple fibroids and large dominant lesions), with estimated blood loss and transfusion events reported alongside complications and length of stay.
Why it might matter to you:
Many gastroenterology and hepatology patients present with iron deficiency, anaemia, anticoagulant/antiplatelet use, or peri-procedural bleeding considerations that intersect with gynaecologic surgical planning. Clear data on technique adoption and complication profiles can help when you co-manage anaemia workups, advise on medication holds, or coordinate timing of endoscopy and surgery in patients with competing procedural needs.
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
